Sofie Deleu

Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long‐acting formulation in healthy volunteers

René Verloes, Sofie Deleu, Nico Niemeijer et al. · HIV Medicine · 2015 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

Brian J. O’Neil, Michael G. Ison, Marie Charlotte Hallouin-Bernard et al. · The Journal of Infectious Diseases · 2020 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Absence of QTc prolongation with domperidone: A randomized, double‐blind, placebo‐ and positive‐controlled thorough QT/QTc study in healthy volunteers

Jeike Biewenga, Chi Keung, Bhavna Solanki et al. · Clinical Pharmacology in Drug Development · 2014 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers

Sofie Deleu, Thomas N. Kakuda, Kurt Spittaels et al. · British Journal of Clinical Pharmacology · 2018 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

Fernando Ferrero, Chien‐Yu Lin, Johannes G. Liese et al. · Pediatric Drugs · 2024 · 13 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16